Cancer and Infectious Diseases

Through truly interdisciplinary collaborations, the cluster aims at discovery and optimization of MDR anticancer and/or antimicrobial lead compounds and validate these by in vitro and in vivo models.

The risk of resistance development will be estimated and investigated through mechanistic studies-

Cluster leader

Associated members

José Moreira, Professor MSO, Molecular & Cellular Pharmacology
Matthias Herth, Associate professor, Herth Group
Lennart Bunch, Associate professor, Bunch Research Group
Dan Stærk, Professor, Bioanalytical Chemistry and Metabolomics Group
Jens Soelberg, Senior curator, Peptides & Proteins